These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Involuntary movement disorders. Still CN Neurol Clin; 1984 Feb; 2(1):71-89. PubMed ID: 6239089 [TBL] [Abstract][Full Text] [Related]
43. [Therapeutical approach to involuntary movements (author's transl)]. Allain H; Sabouraud O Sem Hop; 1979 Feb 8-15; 55(5-6):262-4. PubMed ID: 219537 [TBL] [Abstract][Full Text] [Related]
44. An update on tardive dyskinesia: from phenomenology to treatment. Waln O; Jankovic J Tremor Other Hyperkinet Mov (N Y); 2013; 3():. PubMed ID: 23858394 [TBL] [Abstract][Full Text] [Related]
45. Tetrabenazine in the treatment of Huntington's disease. Paleacu D Neuropsychiatr Dis Treat; 2007; 3(5):545-51. PubMed ID: 19381278 [TBL] [Abstract][Full Text] [Related]
46. An update on new and unique uses of botulinum toxin in movement disorders. Jankovic J Toxicon; 2018 Jun; 147():84-88. PubMed ID: 28888928 [TBL] [Abstract][Full Text] [Related]
48. Myoclonus and movement disorders. Vercueil L Neurophysiol Clin; 2006; 36(5-6):327-31. PubMed ID: 17336777 [TBL] [Abstract][Full Text] [Related]
49. Animal models of l-dopa-induced dyskinesia in Parkinson's disease. Cenci MA; Crossman AR Mov Disord; 2018 Jul; 33(6):889-899. PubMed ID: 29488257 [TBL] [Abstract][Full Text] [Related]
50. Advances in the genetics of movement disorders: implications for molecular diagnosis. Gasser T J Neurol; 1997 Jun; 244(6):341-8. PubMed ID: 9249618 [TBL] [Abstract][Full Text] [Related]
51. Restless legs syndrome and periodic leg movements in patients with movement disorders: Specific considerations. Högl B; Stefani A Mov Disord; 2017 May; 32(5):669-681. PubMed ID: 28186669 [TBL] [Abstract][Full Text] [Related]
52. Treatable Hyperkinetic Movement Disorders Not to Be Missed. Méneret A; Garcin B; Frismand S; Lannuzel A; Mariani LL; Roze E Front Neurol; 2021; 12():659805. PubMed ID: 34925200 [TBL] [Abstract][Full Text] [Related]
53. The pathophysiology of movement disorders. Marsden CD Neurol Clin; 1984 Aug; 2(3):435-59. PubMed ID: 6241955 [TBL] [Abstract][Full Text] [Related]
56. The neuropharmacology of tardive dyskinesia, spontaneous dyskinesia, and other dystonias. Stahl SM; Davis KL; Berger PA J Clin Psychopharmacol; 1982 Oct; 2(5):321-8. PubMed ID: 6127351 [TBL] [Abstract][Full Text] [Related]
57. [Pathophysiology of involuntary movements in adults]. Hashimoto T; Yanagisawa N No To Hattatsu; 1997 May; 29(3):193-8. PubMed ID: 9146023 [TBL] [Abstract][Full Text] [Related]
58. Movement disorders and mitochondrial dysfunction. Hanna MG; Bhatia KP Curr Opin Neurol; 1997 Aug; 10(4):351-6. PubMed ID: 9266161 [TBL] [Abstract][Full Text] [Related]
59. Parkinsonism and other movement disorders in 23 cases of neurocysticercosis. Alarcón F; Cedeño Y; de Yébenes JG Parkinsonism Relat Disord; 2017 Sep; 42():47-53. PubMed ID: 28673613 [TBL] [Abstract][Full Text] [Related]
60. Movement disorders in 30 patients with tuberculous meningitis. Alarcón F; Dueñas G; Cevallos N; Lees AJ Mov Disord; 2000 May; 15(3):561-9. PubMed ID: 10830424 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]